相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。An evaluation of the impact of MAPT, SNCA and APOE on the burden of Alzheimer's and Lewy body pathology
Christian Wider et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2012)
Hippocampal and ventricular changes in Parkinson's disease mild cognitive impairment
Liana Apostolova et al.
NEUROBIOLOGY OF AGING (2012)
Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's disease
Nicolaas I. Bohnen et al.
BRAIN (2011)
CSF amyloid β38 as a novel diagnostic marker for dementia with Lewy bodies
Ezra Mulugeta et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)
White matter lesions in Parkinson disease
Nicolaas I. Bohnen et al.
NATURE REVIEWS NEUROLOGY (2011)
The progression of pathology in Parkinson's disease
Glenda Margaret Halliday et al.
YEAR IN NEUROLOGY 2 (2010)
Correlations between soluble α/β forms of amyloid precursor protein and Aβ38, 40, and 42 in human cerebrospinal fluid
Audrey Gabelle et al.
BRAIN RESEARCH (2010)
Brain Atrophy in Healthy Aging Is Related to CSF Levels of Aβ1-42
Anders M. Fjell et al.
CEREBRAL CORTEX (2010)
The age-related white matter changes scale correlates with cognitive impairment
Y. Xiong et al.
EUROPEAN JOURNAL OF NEUROLOGY (2010)
CSF amyloid-β and tau proteins, and cognitive performance, in early and untreated Parkinson's Disease: the Norwegian ParkWest study
Guido Alves et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)
CSF Aβ42 and tau in Parkinson's Disease with Cognitive Impairment
Thomas J. Montine et al.
MOVEMENT DISORDERS (2010)
Relations between brain tissue loss, CSF biomarkers, and the ApoE genetic profile: a longitudinal MRI study
Duygu Tosun et al.
NEUROBIOLOGY OF AGING (2010)
Ventricular maps in 804 ADNI subjects: correlations with CSF biomarkers and clinical decline
Yi-Yu Chou et al.
NEUROBIOLOGY OF AGING (2010)
3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects
Liana G. Apostolova et al.
NEUROBIOLOGY OF AGING (2010)
In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia
M. A. Burack et al.
NEUROLOGY (2010)
CSF amyloid β 1-42 predicts cognitive decline in Parkinson disease
A. Siderowf et al.
NEUROLOGY (2010)
Effects of cerebrovascular disease on amyloid precursor protein metabolites in cerebrospinal fluid
Per Selnes et al.
FLUIDS AND BARRIERS OF THE CNS (2010)
Decreased Cerebrospinal Fluid Aβ42 Correlates with Brain Atrophy in Cognitively Normal Elderly
Anne M. Fagan et al.
ANNALS OF NEUROLOGY (2009)
CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
Niklas Mattsson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
APOE Alleles in Parkinson Disease and Their Relationship to Cognitive Decline: A Population-based, Longitudinal Study
Martin Wilhelm Kurz et al.
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY (2009)
Incidence of Parkinson's disease in Norway: the Norwegian ParkWest study
G. Alves et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)
Neurochemical Biomarkers in the Differential Diagnosis of Movement Disorders
Brit Mollenhauer et al.
MOVEMENT DISORDERS (2009)
Cerebrospinal Tau, Phospho-Tau, and Beta-Amyloid and Neuropsychological Functions in Parkinson's Disease
Yaroslau Compta et al.
MOVEMENT DISORDERS (2009)
White matter hyperintensities do not impact cognitive function in patients with newly diagnosed Parkinson's disease
Turi O. Dalaker et al.
NEUROIMAGE (2009)
Cognitive impairment in incident, untreated Parkinson disease The Norwegian ParkWest Study
D. Aarsland et al.
NEUROLOGY (2009)
Automated ventricular mapping alignment reveals genetic effects with multi-atlas fluid image in Alzheimer's disease
Yi-Yu Chou et al.
NEUROIMAGE (2008)
Trajectories of brain loss in aging and the development of cognitive impairment
N. E. Carlson et al.
NEUROLOGY (2008)
Apolipoprotein E ε4 allele is associated with the volume of white matter changes in patients with lacunar infarcts
H. M. Wen et al.
EUROPEAN JOURNAL OF NEUROLOGY (2006)
Subtypes of mild cognitive impairment in Parkinson's disease: Progression to dementia
Carmen Cristea Janvin et al.
MOVEMENT DISORDERS (2006)
Visual rating of white matter hyperintensities in Parkinson's disease
MK Beyer et al.
MOVEMENT DISORDERS (2006)
Diagnosis and management of dementia with Lewy bodies - Third report of the DLB consortium
IG McKeith et al.
NEUROLOGY (2005)
Cognitive profile of patients with newly diagnosed Parkinson disease
D Muslimovic et al.
NEUROLOGY (2005)
Mapping hippocampal and ventricular change in Alzheimer disease
PM Thompson et al.
NEUROIMAGE (2004)
Cerebrospinal fluid aβ42 is reduced in multiple system atrophy but normal in Parkinson's disease and progressive supranuclear palsy
B Holmberg et al.
MOVEMENT DISORDERS (2003)
Accurate, robust, and automated longitudinal and cross-sectional brain change analysis
SM Smith et al.
NEUROIMAGE (2002)
Magnetic resonance image tissue classification using a partial volume model
DW Shattuck et al.
NEUROIMAGE (2001)
Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease
HI Hurtig et al.
NEUROLOGY (2000)